Previous 10 | Next 10 |
2023-07-13 11:05:34 ET Summary Merger arbitrage spreads are wide. A number of opportunities with spreads from 9% to 135%. Below you'll find a review of the most interesting setups in the merger arbitrage space. Merger arbitrage is an event-driven investment strategy focu...
2023-07-10 14:50:41 ET Summary The Covid lockdown headwinds could only temporarily dent the relentless progress the company is making, growing revenue, expanding gross margin, and producing substantial operating leverage. We can't think of any even half plausible reason why this r...
2023-06-15 10:33:06 ET 111, Inc. (YI) Q1 2023 Earnings Conference Call June 15, 2023, 07:30 AM ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer ...
2023-06-15 01:28:40 ET 111 press release ( NASDAQ: YI ): Q1 Non-GAAP EPADS of -$0.02. Revenue of $538.3M (23.9% Y/Y). Gross segment profit increased by 22.7% year-over-year, with B2B segment profit increasing by 25.5% year-over-year. For further details see: ...
111, Inc. Announces First Quarter 2023 Unaudited Financial Results PR Newswire SHANGHAI , June 15, 2023 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting pati...
111 to Announce First Quarter 2023 Unaudited Financial Results on June 15, 2023 - Conference Call to Follow PR Newswire SHANGHAI , May 25, 2023 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company com...
2023-04-03 16:41:21 ET Summary Merger arbitrage spreads are wide. There are plenty of opportunities with spreads of up to 118%. This is a review of the most interesting transactions in the merger arbitrage space. Merger arbitrage is an event-driven investment strategy of...
2023-03-26 03:12:33 ET Summary YI is positioned well to take advantage of rapid adoption of telehealth in China. With China opening up, its physical pharmacies and warehousing should pick up. The combination of expected scale and cutting expenses is bringing the company close ...
2023-03-24 01:15:04 ET 111, Inc. (YI) Q4 2022 Earnings Conference Call March 23, 2023 07:30 ET Company Participants Gang Yu - Co-Founder and Executive Chairman Junling Liu - Co-Founder, Chairman and Chief Executive Officer Luke Chen - Chief Financial Officer ...
2023-03-23 02:28:51 ET 111 press release ( NASDAQ: YI ): Q4 Non-GAAP EPADS of -$0.08. Revenue of $601.4M (+19.9% Y/Y). Cash and cash equivalents, restricted cash and short-term investments at the end of 2022 amounted to $133.8M as of December 31, 2022. No...
News, Short Squeeze, Breakout and More Instantly...
111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow PR Newswire SHANGHAI , April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company co...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results PR Newswire SHANGHAI , March 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting p...